Health Catalyst, Inc. — Director's Dealing 2019

Jul 25, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2019-07-24

Reporting Person: Nelli James Patrick Jr. (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6500	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$9.24	2025-02-10	Common Stock (15464.0)		Direct
Stock Option (Right to Buy)	$10.6	2026-10-14	Common Stock (6500.0)		Direct
Stock Option (Right to Buy)	$10.66	2027-04-27	Common Stock (15504.0)		Direct
Stock Option (Right to Buy)	$10.72	2027-10-26	Common Stock (91746.0)		Direct
Stock Option (Right to Buy)	$10.8	2028-09-27	Common Stock (225000.0)		Direct

Footnotes

F1: 25% of the shares vested on February 10, 2016; and the remaining 75% vest in 36 equal monthly installments thereafter.

F2: 25% of the shares vested on October 14, 2017; and the remaining 75% vest in 36 equal monthly installments thereafter.

F3: 25% of the shares vested on April 27, 2018; and the remaining 75% vest in 36 equal monthly installments thereafter.

F4: 25% of the shares vested on October 26, 2018; and the remaining 75% vest in 36 equal monthly installments thereafter.

F5: The stock option vests based on the satisfaction of both a time-based vesting condition and a liquidity-based vesting condition. The time-based vesting condition is satisfied as follows: 25% of the shares subject to the stock option will satisfy the time-based vesting condition on September 25, 2019 and the remaining 75% will satisfy the time-based vesting condition in 36 equal monthly installments thereafter, generally subject to the named executive officer's continuous service relationship with the Company through each applicable vesting date. The liquidity-based vesting condition is satisfied upon the earlier of the Company's initial public offering or a sale of the Company.